Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester.
Our aim is to investigate visfatin concentration and its relationship to glycated hemoglobin (HbA1c), insulin resistance, lipid parameters, and neonatal birth weight in women with gestational diabetes mellitus (GDM). In our study group, there were 47 women with GDM and 31 women with normal glucose tolerance (NGT) between 33-39 weeks of gestation. Plasma visfatin levels were significantly decreased in pregnant women with GDM compared to those with NGT (p=0.001). Homeostasis model assessment-insulin resistance (HOMA-IR) levels were higher in the GDM group than in the NGT group (p=0.006). In all subjects, plasma visfatin levels were negatively correlated with HOMA-IR, post-prandial blood glucose, triglycerides, and VLDL cholesterol (p<0.05). We did not observe any statistically significant correlation between the plasma visfatin levels and the selected parameters in the GDM group, but in the NGT group plasma visfatin levels were negatively correlated with HOMA-IR (r=-0.36, p=0.04). There was no correlation between visfatin concentrations and fetal birth weight in either group (p>0.05). By regression analysis, having GDM was found to be the only significant determinant (t=3.5, p=0.001) of visfatin concentration (R=0.39, r2=0.15). We conclude that women with GDM have significantly decreased visfatin concentrations in the third trimester. Future studies are required to establish the exact role of visfatin in the pathogenesis of GDM.
Akturk
M
M
Department of Endocrinology and Metabolism, Faculty of Medicine, Gazi University, Ankara, Turkey. mujdeakturk@hotmail.com
Altinova
A E
AE
Mert
I
I
Buyukkagnici
U
U
Sargin
A
A
Arslan
M
M
Danisman
N
N
D000328:Adult; D016640:Diabetes, Gestational / Q000097:blood / Q000201:enzymology; D005260:Female; D005865:Gestational Age; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D054409:Nicotinamide Phosphoribosyltransferase / Q000097:blood*; D011247:Pregnancy; D011263:Pregnancy Trimester, Third / Q000378:metabolism*; D013223:Statistics as Topic
D006442:Glycated Hemoglobin; D054409:Nicotinamide Phosphoribosyltransferase; C517652:hemoglobin A1c protein, human
J Soc Gynecol Investig. 2006 Jul;13(5):364-7
16814166
Clin Sci (Lond). 2006 May;110(5):605-9
16489932
Diabetes Care. 2004 Jan;27 Suppl 1:S88-90
14693936
Clin Chem. 2007 Aug;53(8):1477-83
17586594
Obesity (Silver Spring). 2006 Nov;14(11):1886-9
17135602
Diabetologia. 2007 May;50(5):1033-7
17334748
Acta Paediatr. 2007 Apr;96(4):526-9
17391471
Clin Endocrinol (Oxf). 2004 Nov;61(5):544-52
15521955
Diabetes. 2006 Oct;55(10):2871-5
17003355
Clin Endocrinol (Oxf). 2007 Mar;66(3):434-9
17302880
Pflugers Arch. 2007 Sep;454(6):971-6
17429683
Diabetes Care. 2002 Oct;25(10):1862-8
12351492
J Clin Invest. 2005 Mar;115(3):485-91
15765129
J Clin Endocrinol Metab. 2006 Apr;91(4):1578-81
16449335
J Clin Endocrinol Metab. 2006 Jan;91(1):295-9
16234302
Diabetes Care. 2007 Jul;30(7):1889-91
17416788
Diabetes Care. 1998 Aug;21 Suppl 2:B19-26
9704223
Pediatrics. 2007 Jun;119(6):e1314-8
17502346
Metabolism. 2007 Apr;56(4):565-70
17379018
J Perinat Med. 2007;35(4):326-9
17511597
Diabetologia. 2006 Aug;49(8):1909-14
16736128
Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):544-8
17177135
Diabetes Care. 2007 Feb;30(2):348-53
17259506
Diabetologia. 1985 Jul;28(7):412-9
3899825
Gynecol Obstet Invest. 2006;61(2):115-8
16272815
Am J Obstet Gynecol. 2002 Oct;187(4):1051-8
12389004
J Endocrinol Invest. 2007 Feb;30(2):138-44
17392604